Search

The primary objective of the current framework was to synthesize novel mononuclear 1:1:1 complexes involving FeLG, CoLG, NiLG, CuLG, and ZnLG, where the ligand (L) is identified as 4-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)hydrazono]methylphenyl-4-methylbenzenesulfonate, and glycine (G) serves as the coligand. Comprehensive characterization of the investigated complexes was achieved through various analytical techniques, including FTIR, UV-Vis spectroscopy, elemental analysis, mass spectra, magnetic susceptibility measurements, molar conductivity assessments, and thermogravimetric analysis (TGA). The determination of stoichiometry was performed employing the molar ratio technique, revealing the octahedral geometry inherent in the isolated metal complexes. Employing a density functional theory (DFT) approach, the molecular structures of the designated compounds were theoretically elevated, and quantum chemical descriptors were derived to provide a deeper insight into their electronic properties. Furthermore, the inhibitory potential of these compounds against fungal strains and pathogenic bacteria prevalent in the Arab environment was evaluated using the disc diffusion method, emphasizing their role in combating diseases affecting humans, animals, and plants. Notably, the metal complexes exhibited superior antibacterial activity, as evidenced by a higher activity index. Molecular docking investigations were conducted to ascertain the inhibitory effects of the compounds on the 1FJ4 protein, with ZnLG emerging as the compound with the highest binding affinity. These results suggest the promising candidacy of these compounds as antimicrobial agents, particularly in the context of combating bacterial and fungal infections. [ABSTRACT FROM AUTHOR]

New 2-[(4-[(4-methylphenyl)sulfonothioyl)methylene]aminobenzoic acid ligand-Co(II), Ni(II), and Cu(II) complexes are synthesized and characterized in this article. Elemental analysis, mass spectroscopy, conductivity tests, magnetic susceptibility, Fourier transform infrared spectroscopy, thermogravimetric analysis, electronic absorption spectroscopy, and density functional theory calculations were used to determine the coordination mode, and geometry of the synthesized compounds. The Schiff-base ligand was shown to be mononegatively charged and coordinate to metal ions in a bi-dentate mode through azomethine nitrogen (-CH=N-) and carboxylic Oxygen (-COOH). Density functional theory (DFT) calculations were performed in addition to the experimental data to assess the most probable structures of the complexes. In addition, the biological activities of these compounds were evaluated by in vitro antibacterial and antifungal assays. These novel Co(II), Ni(II), and Cu(II) compounds were shown to be active against a wide variety of microorganisms, including Gram-positive and Gram-negative bacteria, as well as fungi. Following that, molecular docking was used to analyze the complexes' interactions with bacterial proteins, validating the therapeutic potential of the metal-containing compounds. [ABSTRACT FROM AUTHOR]

The present framework has as its goal the design and synthesis and characterization of new mononuclear 1:1:1 (M:L:Q) mixed-ligand complexes, including FeLQ, CoLQ, NiLQ, CuLQ, and ZnLQ. The "L," is the 4-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)hydrazono]methylphenyl 4-methylbenzenesulfonate, while the "Q," is the 8-hydroxy quinoline. According to the findings, L and Q ligands each play the role of a neutral bi-dentate NN and a monobasic bi-dentate ON ligand, respectively. The findings demonstrated an octahedral shape. The density functional theory (DFT) technique was employed, and the quantum chemical descriptors were assessed, to optimize the molecular structure of the compounds. An in vitro investigation was carried out to investigate the antibacterial and antifungal activities of the compounds. According to the findings, the activity of metal complexes as potential candidates for use as antibiotics and antifungals is much greater than that of their free ligands. The in-silico inhibition of the 1fj4 protein was investigated using molecular docking. ZnLQ complex was the one that inhibited the 1fj4 protein with the greatest degree of success. The fact that this is the case lends credence to the notion that these compounds have the potential to function as launchpads for the development of new classes of antibiotics. [ABSTRACT FROM AUTHOR]

The aim of the present framework is to synthesize and characterize new cobalt(II) (C1), nickel(II) (C2), and copper(II) (C3) mixed‐ligand complexes incorporating bioactive 8‐hydroxyquinoline moiety, with synthesized 2‐(1H‐benzimidazol‐2‐yl)guanidine (BG) ligand, for investigating their antibacterial, antifungal, and anti‐inflammatory potential. The metal complexes structure had been elucidated by the use of a wide range of methods, including elemental analysis, Fourier transform infrared (FT‐IR), mass spectra, UV–vis spectra, magnetic susceptibility, thermogravimetric (TG) analysis, and the molar ratio technique of stoichiometry analysis. The resulted metal complexes were found to have octahedral structures in molar ratio of M:BG:Qu as 1:1:2. Density functional theory (DFT) had been used to determine the optimal molecular structure and quantum chemical properties of each material. After that, we looked into the metal complexes' anti‐inflammatory and antibacterial properties by testing them in vitro. The disc diffusion test showed that the metal complexes were far more potent against bacteria/fungi than the original ligands. The egg albumin denaturation technique showed that the metal complexes were more potent anti‐inflammatory candidates than the free ligands and comparable with the standard reference. Molecular docking analysis against 5JQ9, 6CLV, and cyclooxygenase‐2 (COX‐2; 5IKT) confirmed the bioactivity behavior of the metal complexes. C3 has the greatest binding affinity among the metal complexes tested. These findings proposed that the metal complexes could form the basis of future antibiotics and anti‐inflammatory candidates. Finally, the in vitro activities were reviewed in relation to the DFT and molecular docking data. [ABSTRACT FROM AUTHOR]

The wide biological actions of triazolotriazine hybrids, benzene‐sulfonamide derivatives, exhibit a good chance of displaying in vitro anti‐inflammatory effects. An operationally simple one‐pot, three‐component, and convenient synthesis method is used toward the synthesis of a series of diverse 2‐(2‐(4‐amino)‐1,3,5‐triazaspiro‐1,4‐dien‐2‐yl) hydrazinyl)‐N‐(4‐sulfamoylphenyl)‐2‐thioxoacetamides, which generated via reaction of 2‐hydrazinyl‐N‐(4‐sulfamoylphenyl)‐2‐thioxoacetamide, cyanoguanidine, and cyclic/acyclic ketones and were characterized by spectral analysis (IR, Nuclear Magnetic Resonance: 1H‐NMR, 13C‐NMR, and elemental analysis). The spirotriazolotriazine derivatives are obtained with up to 95% yield, and their structure–activity relationship was discussed. All compounds were tested for in vitro anti‐inflammatory potential using the inhibition of RBC hemolysis technique and COX inhibition assay. The results from RBC hemolysis technique demonstrated that almost all evaluated compounds exhibited significant in vitro anti‐inflammatory efficacy. More specifically, compounds 7, 8, and 12 have superior membrane stability over indomethacin as a standard drug. At concentrations of 400, 600, 800, and 1000 μg/mL, compound 12 demonstrated highly significant inhibition of RBC hemolysis with 95.2%, 97.3%, 98.9%, and 99.8%, respectively, compared with indomethacin at the same concentrations (94.5%, 97.3%, 98.5%, and 99.3%, respectively). COX assay indicated that compounds 7, 8, and 12 exhibited excellent COX‐2 inhibition percentage (98.51 ± 0.01, 98 ± 0.01, and 98.97 ± 0.06, respectively) at 150 μg/mL using indomethacin (97.3 ± 0.005). Furthermore, an investigation using molecular docking against COX‐2 (pdb ID: 5IKT) was used to analyze the anti‐inflammatory properties of all studied substances. When compared to indomethacin, molecular docking research showed a strong connection with the intended protein and an elevated docking score. According to in vitro anti‐inflammatory action and computational approach, they show promise as a therapeutic candidate for the treatment of inflammatory diseases. [ABSTRACT FROM AUTHOR]

The mpox (previously monkeypox) outbreak in more than 100 non-endemic countries in 2022 posed a serious global health concern. Mpox is emerging as a global public health threat from a seemingly neglected disease. A42R profilin-like protein from mpox virus (PDB ID: 4QWO) could be a preferred target lead. The binding affinity of commonly used drugs/mAbs (tecovirimat, brincidofovir, cidofovir) for A42R profilin-like protein was examined in silico through molecular docking. Further, the results were compared with those of the phytochemicals curcumin, rutin, and theaflavin. Tecovirimat (-7.31 kcal/mol, IC50 = 4.39 lM) and theaflavin (-6.99 kcal/mol, IC50 = 7.54 lM) had the highest affinities. Molecular dynamics simulation of the theaflavin-4QWO complex was performed to ascertain the stability of ligand-protein interactions in natural charge, molecular electrostatic potential, and frontier molecular orbital analyses. The predicted QSAR and pharmacokinetic properties of all compounds were evaluated to find a suitable candidate for designing and developing new drugs. The evaluated log P values for brincidofovir and tecovirimat were higher than those of the other drugs in the QSAR study. Theaflavin had an impressive log P of 4.77, which hints at its high biological activity. The findings recommend further in vitro experimental validation to develop potential low-cost mpox therapies. [ABSTRACT FROM AUTHOR]

The main purpose of the current work is the design and synthesis of new Co(II), Ni(II), and Cu(II) mixed‐ligand complexes derived from simple and easily synthesized azo‐ligand, [2‐(phenylthio)phenyl]diazenyl}‐2‐naphthol (HTe), with 8‐hydroxyquinoline (HQ) to improve and understanding their action as an antimicrobial candidate and their therapeutic efficiency with the aid of density functional theory (DFT) calculations and molecular docking studies, which considered a hot topic of research. To access this target, and to explore the effect of changing metal ion type, the new Co(II), Ni(II), and Cu(II) mixed‐ligand complexes were firstly synthesized and characterized via elemental analysis, Fourier transform infrared (FT‐IR), mass spectrometry, ultraviolet–visible spectroscopy, magnetic susceptibility, thermogravimetric analysis (TGA), and stoichiometry analysis molar ratio method. Upon further inspection, the octahedral structures of the isolated metal complexes were found. The compounds' molecular structures were optimized using the DFT technique, and the quantum chemical parameters were evaluated. To determine whether or not these compounds are effective in preventing the spread of harmful bacteria and fungi, two of the most common environmental pollutants in the Arab world, a disc diffusion test was conducted. The prepared complexes were much more efficient against bacteria than the pristine ligands. Molecular docking experiments helped researchers learn which medicines inhibited the 1fj4 protein. All other tested compounds were found to have lower binding affinities than CuTeQ. This suggests that these compounds have the potential as starting points for the production of new classes of antibiotics. Finally, a correlation of the in vitro activity with the DFT and molecular docking data has been done and discussed. [ABSTRACT FROM AUTHOR]

A new heterocyclic azo dye ligand (L) was synthesized by the combination of 4-amino antipyrine with 4-aminophenol. The new Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), and Cd(II) complexes were synthesized in excellent yields. The metal chelate structures were elucidated using elemental analyses, FT-IR, 1H-NMR, mass, magnetic moment, diffused reflectance spectral and thermal analysis (TG-DTG), and molar conductivity measurement. According to the FT-IR study, the azo dye ligand exhibited neutral tri-dentate behavior, binding to the metal ions with the azo N, carbonyl O, and protonated phenolic OH. The 1H-NMR spectral study of the Zn(II) complex supported the coordination of the zo dye ligand without proton displacement of the phenolic OH. Diffused reflectance and magnetic moment studies revealed the octahedral geometry of the complexes, as well as their good electrolytic nature, excepting the Zn(II) and Cd(II) complexes, which were nonelectrolytes, as deduced from the molar conductivity study. The theoretical calculations of optimized HOMO–LUMO energies, geometrical parameters, electronic spectra, natural atomic charges, 3D-plots of MEP, and vibrational wavenumbers were computed and elucidated using LANL2DZ and 6-311G (d, p) basis sets of density functional theory (DFT) with the approach of B3LYP DFT and TD-DFT methods. The ligand and complexes have been assayed for their antimicrobial activity and compared with the standard drugs. Most of the complexes have manifested excellent antimicrobial activity against various microbial strains. A molecular docking investigation was also performed, to acquire more information about the binding mode and energy of the ligand and its metal complexes to the Escherichia coli receptor using molecular docking. Altogether, the newly created ligand and complexes showed positive antibacterial effects and are worth future study. [ABSTRACT FROM AUTHOR]

Novelmanganese(II), iron(III), cobalt(II), nickel(II), and copper(II) chelates were synthesized and studied using elemental analysis (EA), infrared spectroscopy, mass spectrometry, ultraviolet-visible spectroscopy, and conductivity, as well as magnetic measurements and thermogravimetric analysis (TG). The azo-ligand 1-[(4-nitrophenyl)diazenyl]-2-naphthol (HL) chelates to the metal ions via the nitrogen and oxygen centers of the azo group and the hydroxyl, respectively. The amounts of H2O present and its precise position were identified by thermal analysis. Density functional theory (DFT) was employed to theoretically elucidate the molecular structures of the ligand and the metal complexes. Furthermore, the quantum chemical parameters were also evaluated. The antimicrobial properties were evaluated against a group of fungal and bacterial microbes. Interestingly, the bioactivity of the complexes is enhanced compared to free ligands. Within this context, the CuL complex manifested the lowest activity, whereas the FeL complex had the greatest. Molecular docking was used to foretell the drugs' binding affinity for the structure of Escherichia coli (PDB ID: 1hnj). Protein-substrate interactions were resolved, and binding energies were accordingly calculated. [ABSTRACT FROM AUTHOR]

Two new Fe (III) and Cr (III) complexes had been synthesized and structurally characterized. The new complexes were based on 2‐methyl‐benzimidazole (MB) and salicylic acid (H2L). Elemental analyses, Fourier transform infrared spectroscopy, UV‐–Vis, mass spectra, conductivity, magnetic, and thermal measurements were used to formulate the compounds structures. The results revealed octahedral geometry for both of Fe (III) and Cr (III) complexes. Structure elucidation of these complexes was also supported by density functional theory (DFT) along with optimized geometrical parameters. Natural bond orbital analysis and molecular electrostatic potential were also investigated. Electronic absorption spectra were theoretically performed using the time‐dependent TD‐DFT/B3LYP in gas phase and acetonitrtile as a solvent. Furthermore, the bio‐mimicking activity as antimicrobial and anti‐inflammatory activity of the understudy compounds was in vitro screened. The results showed that the Fe (III) and Cr (III) complexes exhibited higher pathogenic action than the free ligands. Molecular docking investigation against 3T88 (E. Coli) and 5IKT (Cyclooxygenase‐2) was carried out to provide deep insights into their role in inhibiting the growth of pathogenic microbes. [ABSTRACT FROM AUTHOR]

Herein, new Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) complexes incorporating 4‐{[(2‐hydroxyphenyl)imino]methyl}phenyl 4‐methylbenzenesulfonate Schiff‐base ligand (HL) were designed, synthesized, and characterized. The structure of the new compounds was elucidated based on spectroscopic techniques (nuclear magnetic resonance [NMR], ultraviolet–visible [UV‐vis], infrared [IR], mass), magnetic, conductivity, thermal analysis (thermogravimetric analysis [TGA], differential thermal analysis [DTA]) measurements, in addition to complex stoichiometry determination using molar ratio and Job's methods. The new complexes showed an interesting structural variation: square‐planar (in the case of NiL), tetrahedral (in the case of CuL), and octahedral (in the case of FeL2, CoL2, and ZnL2). Furthermore, density functional theory (DFT) calculations were performed to obtain deep insights into the structural features, orbital interactions, and electronic chemical descriptors evaluation. Moreover, the anti‐inflammatory behavior of the titled compounds was in vitro investigated. Interestingly, the ZnL2 complex showed the highest activity, whereas the CuL complex showed the lowest activity compared with the other compounds. In order to ascertain the bioactivity of the present compounds, their efficacy was compared with previously reported compounds showing high activity. The anti‐inflammatory activity was supported by molecular docking analysis against cyclooxygenase‐2 (COX‐2) enzyme (PDB ID: 5IKT), which confirms the bioactivity behavior. The obtained results indicated that the titled compounds could be promising anti‐inflammatory candidates. [ABSTRACT FROM AUTHOR]

The reaction of the synthesized 2‐(4,5‐diphenyl‐1H‐imidazol‐2‐yl) phenol, (HL) ligand with FeIII, CoII, NiII, CuII, and ZnII ions at room temperature resulted in the formation of the five complexes; [Fe(L)2(H2O)(Cl)]·2H2O and [M(L)2)]·nH2O [M = Co, Zn (n = 2), Ni, Cu (n = 1)]. The ligand and its complexes were characterized based on elemental analyses, spectral, magnetic and molar conductance measurements. The molecular and electronic structure of the ligand and its complexes was optimized theoretically and the quantum chemical parameters were calculated. The results revealed an interesting geometrical variation; octahedral for FeL, seesaw for CoL, distorted square planar for NiL and CuL, as well a tetrahedral arrangement for ZnL. The HL ligand and its metal complexes were screened against the growth of pathogenic bacteria [Escherichia coli (G–) and Bacillus cereus (G+)] and fungi (Aspergillus fumigatus) in terms of the minimum inhibitory concentration (MIC). The metal complexes showed high enhancement as antimicrobial candidates with lower MIC values compared with their parent ligand. Structure activity relationship formula was quantified by correlating the experimental MIC values with theoretical electronic chemical properties. Molecular docking of the complexes against CYP51B protein of A. fumigatus, the target enzyme for the antimicrobial reagents, was achieved to find the best orientation of the substrate, which would form a stable complex with overall minimum energy. The docking results enhanced the activity of the imidazole‐based complexes as promising antimicrobial candidates. [ABSTRACT FROM AUTHOR]

[Display omitted] • New Cr(III), Mn(II), Fe(III), Ni(II), Cu(II), and Zn(II) complexes were synthesized and characterized. • 3D geometry was optimized using DFT approach. • In vitro antimicrobial activity was screened. • Molecular docking against 1HNJ protein was explored. • Drug-Likeness properties were investigated based on Lipinski rule. Herein, new Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes based on azocoumarin ligand, 2-[(E)-(2-oxo-2H-chromen-6-yl)diazenyl]-1-phenylbutane-1,3-dione (L), were synthesized and characterized via elemental analyses, IR, mass, UV–Vis spectra, magnetic susceptibility, conductivity measurements, and thermogravimetric analysis (TG). From IR spectra, it was elucidated that the azocoumarin ligand behaves as a neutral bi-dentate ligand and coordinates to the metal ions through the azo Nitrogen and carbonyl Oxygen. Number and position of the water molecules were investigated through thermal analysis. The molecular structures of the ligand (L) and its metal complexes were optimized theoretically using density functional theory (DFT) for various possible orientations of the H 2 O and Cl moieties around the metal-center, to find out the most reliable coordination modes. Moreover, the quantum chemical parameters were evaluated. The bioactivity of the ligand and its complexes were screened for their in vitro anti-bacterial and anti-fungal activity against series of pathogenic bacterial and fungal strains. The metal complexes possess high biological activity with low minimum inhibition concentration (MIC) against different organisms. In order to ascertain the bio-effect of the present compounds, their MIC was compared with previously reported MIC showing lower MIC values. Molecular docking was used to predict the binding efficiency between the prepared compounds and the receptor of E. coli (1HNJ), the target enzyme for the antimicrobial reagents. The protein-substrate interactions were investigated and the binding energies were calculated. The drug-likeness and ADMET prediction showed compliance with the Lipinski rule, and the compounds were found to have good absorption, distribution, metabolism, and excretion generally. The results were very encouraging, so we can say that these products are biologically active and can be used later in other applications towards drug development. [ABSTRACT FROM AUTHOR]

• New FeLphen, Colphen and Nilphen complexes were synthesized, characterized and theoretically investigated. • Optimization and vibrational study of the new compounds were performed using DFT approach. • The reactivity of the new compounds was evaluated using frontier orbitals studies. • In vitro evaluation of the synthesized compounds shows a good antimicrobial activity. • Molecular docking against 2VF5, 4FXQ, and 3cku was explored. • The experimental results are in good agreement with the theoretical investigation. Three new FeLphen, CoLphen and NiLphen hetero-ligand were synthesized, characterized and theoretically investigated. The new complexes were based on phenylalanine (Hphen) and 1-{(E)-[(4- methylphenyl) imino ]methyl}-2-naphthol Schiff-base (HL). The results showed interesting structural variety as octahedral for FeLphen ([F e (L)(phen)(C l)(H 2 O)]), CoLphen ([C o (L)(phen)(H 2 O) 2 ]) and tetrahedral for NiLphen ([N i (L)(phen)]). The molecular properties, geometric optimization, vibrational, frontier molecular orbital, and energy evaluation of the new complexes were characterized theoretically using density functional theory (DFT) approach. The calculations were performed to find out the most reliable cis /trans (Chloride and/or H 2 O) and the (HL/Hphen) orientations around the Fe(III)/Co(II) and Ni(II) center. The calculations revealed that trans-H 2 O/Cl-cis-N HL /N Hphen & cis-H 2 O/H 2 O-cis-N HL /N Hphen and cis-N HL /N Hphen were the most stable orientations for the FeLphen, CoLphen and NiLphen, respectively. Furthermore, the antibacterial and antifungal activity of the titled compounds was in vitro screened. The results showed that the metal complexes exhibited higher pathogenic effect than the free ligands against the selected microbes. Molecular docking investigation against 2VF5, 4FXQ, and 3cku, was carried out to provide deep insights into their role in inhibiting the growth of pathogenic microbes. Comparative analysis elucidated higher antibacterial and antifungal activity of the titled compounds compared with literature survey. [Display omitted] [ABSTRACT FROM AUTHOR]

• Preparation of some new mixed ligand complexes and their structural inspection • Geometry optimization for structural verification using DFT calculation • DNA interaction and biomedical evaluation of the prepared compounds • Molecular docking inspection for predicting of the biomedical evaluation The fabrication and structural identification of mixed ligand chelates resulting from 1-(1H-benzimidazol-2-yl) guanidine (BIG = main ligand) and 1,10-Phenanthroline (phen) (secondary ligand). The tested compounds were investigated using TGA, CHN, spectra analysis (FT-IR, Mass spectra, NMR), melting point, magnetic moments, molar conductance, Ultraviolet–Visible spectroscopy as well computational studies. The conductance results showed that the tested Pd(II), VO(II) and Ag(I) chelates have electrolytes in fresh solutions of DMSO lies in the range 38.12–118.87 Ω−1 cm2 mol−1 except, Cu(II) chelate is a non-electrolyte it is value equal 15.16 Ω−1 cm2 mol−1. FT-IR spectrum displays that the tested main ligand is coordinated with metal ions in a bi-dentate behavior with N, N donor sites of the HN=C and C=N. While the second ligand coordinated with metal ions through its N 2 atom in the pyridine ring. Moreover, the obtained analytical data regarding complexation in solution, molar ratio and continuous variation methods suggest 1M: 1 L molar ratio. Also the stability constant of tested complexes was identified in solution state and the formation constants (Kf) were evaluated by applying continuous-variation method. Stability of complexes was arranged by BIGPAg > BIGPVO > BIGPCu > BIGPPPd in agreement with K f values. The pH profile revealed that the wide range of pH stability of the tested complexes is at pH = 4- 10 in most of them. Magnetic and electronic spectra are applied to deduce the coordinating ability of the tested ligands and the geometric structure of the studied chelates. That data of magnetic susceptibility for ternary mixed chelates are locked to an octahedral geometry for Cu(II) & VO(II) chelates due to the data of (μeff = 1.8 and 1.83 B.M) respectively and Pd(II) and Ag(I) chelates are diamagnetic with square planar and tetrahedral geometry, respectively. The TGA study of these studied complexes displays that the hydrated H 2 O, acetate, nitrate, and acetylacetonate anions are removed in the first (45°C-180°C) and second degradation steps followed directly by degradation of the studied ligands in the following stages. The thermodynamic factors, like ΔS*, ΔH*, E*, A and ΔG* are evaluated from the TGA curves and explained. The DFT/B3LYP computation method was applied for the estimation of the MEP, (HUMO & LUMO) energy for the studied compounds. In-silico assay was executed by two different approaches over compounds to evaluate their biological behavior and degree of interaction with biological systems, before practical application. BIGPPd complex displayed priority in interaction with various protein. In-vitro assay was then carried out for compounds against different microbes and BIGPPd showed high antimicrobial activity with inhibition zones are established to be 45.75 ± 0.10 and 41.95 ± 0.05 mm against B. Cereus and G. Candidum at 25 µg/mL. Also, their cytotoxic behavior was examined against MCF-7, HepG2 and HCT-116 carcinoma cell lines, high cytotoxicity was clearly recorded with BIGPPd complex with IC 50 % are established to be (5, 6.25 and 7.14 µg/mL) respectively. Furthermore, antioxidant activity was examined, and the complexes exhibited high reactivity with trapping free radicals. The BIGPPd exhibited significant free radical scavenging activity with an IC 50 value of 20.15 μg/ml. The interaction of metal chelates with DNA was detected by gel electrophoreses, viscosity and spectral studies. Spectrophotometric titration and viscosity studies expose that each of tested complex is an avid binder to DNA. The intrinsic binding constants were calculated for all the tested compounds could bind to Ct-DNA generally through replacement, intercalative mode & minor groove binding of interactions with the sequence: BIGPVO (6.05×104) > BIGPCu > BIGPPd> BIGPAg >BIG (1.16×103). This may be due to enhanced hydrophobic & electrostatic interaction of aromatic rings. Finally, such complexes may be considered as a promising bioactive agent. [Display omitted] [ABSTRACT FROM AUTHOR]

• Novel Co(II) (C1), Ni(II) (C2), & Cu(II) (C3) mixed-ligand complexes have been synthesized. • Their antibacterial, antifungal & anti-inflammatory efficacy have been the focus of recent studies. • The C1, C2, and C3 complexes were found to be more potential anti-inflammatory candidates than the free ligands. • DFT & molecular docking results were correlated with in vitro activities & debated. Here, we combine the simple and readily synthesized azo-ligand [1-((4-Hydroxyphenyl)azo)-2-naphthalenol (PNP)] with 8-hydroxyquinoline (QPH) to develop and synthesize novel Co(II) (C1), Ni(II) (C2), and Cu(II) (C3) complexes. Their antibacterial, antifungal, and anti-inflammatory efficacy had been the focus of recent studies. This objective was reached by first synthesizing and characterizing novel C1, C2, and C3 complexes using elemental analysis, mass spectra, Fourier-transform infrared, electronic spectra, magnetic, Thermal, and molar ratio analysis. Octahedral structures were identified for the C1, C2, and C3 complexes. Quantum chemical characteristics and an optimized molecular structure for each substance were calculated using Density Functional Theory (DFT). To find out whether these substances are efficient in stopping the diffusion of dangerous microorganisms that are the most popular environmental pollutants, a disc diffusion check was carried out. All complexes demonstrated significantly larger inhibition zones (IZ) against both Gram-negative and Gram-positive bacteria compared to free ligands, with increases ranging from 70 % to 134 %. Against fungal strains, C2 and C3 showed the most significant enhancements, exhibiting up to 202 % increase in IZ compared to QPH and PNP. All complexes displayed reductions in minimum inhibitory concentration (MIC) compared to the free ligands against both bacteria and fungi. The most notable reductions were observed against Gram-negative bacteria, with complexes C1-C3 achieving up to 50 % reduction in MIC compared to QPH and PNP. Against fungal strains, complexes C2 and C3 generally showed better activity, with up to a 25 % reduction in MIC compared to the free ligands. Furthermore, the Egg albumin denaturation technique was studied to assess the anti-inflammatory activity. At a concentration of 10 %, C3 exhibited the highest activity at 83.26 %. As the concentration increased to 50 %, C3 maintained its superiority at 83.42%, followed closely by C2 at 78.39 %. At 100 %, C3 again displayed the highest activity at 84.13 %, while C2 and C1 showed comparable activity. Remarkably, at higher concentrations (250 % and 500 %), C3 consistently outperformed all other compounds, reaching an impressive antioxidant activity of 86.29 % at 250 % concentration. The antibacterial, antifungal, and anti-inflammatory activity was assisted by molecular docking investigation against 5JQ9 and 6CLV from Escherichia coli and Staphylococcus aureus , and COX-2 (5IKT) as anti-inflammatory target enzyme, which confirms the bioactivity behavior. In the interaction with 5JQ9, 6CLV, and 5IKT, C3 displayed strong H-donor and ionic interaction with (GLY42 and ASP85), (GLY42 and ASP85) and (CYS41 and GLY45). Notably, C3 consistently exhibited strong interactions across all three receptors, emphasizing its potential as an effective compound. These quantitative results provide valuable insights into the molecular interactions and binding affinities, supporting the bioactivity behavior observed in the experimental assays. In the end, DFT and molecular docking results were correlated with in vitro activities and debated. [Display omitted] [ABSTRACT FROM AUTHOR]

• Two new series of N -4 piperazinyl sulfur containing Ketene S,S -acetals and Ketene N,S -acetals, based norfloxacin analogues had been synthesized and characterized. • The synthesized compounds had been evaluated against pathogenic fungi and Gram-positive/Gram-negative bacteria. • Synthetic compounds demonstrated comparable efficacy to norfloxacin against tested bacteria, with MIC values ranging from 1.56 to 50 µg/ml. • Compounds 8, 9 , and 10 displayed potent antifungal activities, surpassing Griseofulvin. • Molecular docking studies revealed diverse binding of target compounds with 1HNJ protein from E. coli , indicating potential as 1HNJ-targeting agents. • Density functional theory analysis for 8, 9 , and 10 , along with norfloxacin, showed comparable HOMO-LUMO energy differences, softness, and hardness, highlighting the significance of charge transfer at the molecular level. The in vitro antimicrobial activity was investigated for two new series of N -4 piperazinyl sulfur containing Ketene S,S-acetals and Ketene N,S-acetals, based norfloxacin analogues against two pathogenic fungi and four pathogenic Gram-positive and Gram-negative bacterial strains. The majority of synthetic compounds exhibit comparable efficacy to norfloxacin against the four tested bacteria. The MIC of the compounds varied from 1.56 to 50 µg/ml. Compounds 8, 9 , and 10 exhibited good antifungal activities compared to Griseofulvin. Most of the tested compounds showed promising antibacterial activity. Compounds 4, 9 and 10 showed twice the activity against E. coli (MIC = 3.12 µg/ml), while 6 showed twice the activity against P. aeruginosa (MIC = 6.25 µg/ml), compared to norfloxacin. Similarly, 5 and 9 showed double the activity against k. pneumonia (MIC = 3.12 µg/ml) and 3 showed higher activity against the Gram positive S. aureus. Compounds 1–10 underwent a comprehensive molecular docking investigation with 1HNJ protein from E. coli and showed diverse binding. The binding affinities, expressed as docking scores (S, kcal/mol), exhibited a range from −8.67 (9), −8.47 (10), and −8.45 (8), to −6.85 (7), and −6.47 (3) Kcal/mol. The outcomes of this investigation provide compelling evidence for the inhibitory potential of these compounds against 1HNJ, suggesting a new 1HNJ-targeting agents. Results of Density Functional Theory analysis for 8, 9 and 10 and norfloxacin showed that the calculated HOMO-LUMO energy differences (Δ E), softness, and hardness for compounds 8, 9 and 10 were found to be comparable to that of norfloxacin, emphasizing the significance of charge transfer at the molecular level. [Display omitted] [ABSTRACT FROM AUTHOR]

The exploration encompassed the synthesis and characterization of two innovative complexes, namely FePHNS and CuPHNS, employing a diverse array of analytical techniques such as elemental analysis, infrared and ultraviolet-visible spectroscopy, mass spectrometry, molar conductivity measurements, magnetic susceptibility assessments, and thermal analysis (TGA). In the spectral domain, infrared spectroscopy substantiated the tridentate ONS coordination of the PHNS ligand to the central metal atom. Thermal analysis offered valuable insights into the distribution and content of water molecules within the complexes. Density functional theory (DFT) calculations were harnessed to validate the molecular structures of both the PHNS ligand and its complex entities, providing an intricate comprehension of their quantum chemical parameters. The investigation extended to an evaluation of the in vitro antibacterial, antifungal, and antioxidant efficacy of the PHNS ligand and its complexes, revealing heightened biological activities for the complexes in comparison to the free PHNS ligand, notably with the CuPHNS complex demonstrating the highest activity, while the PHNS ligand exhibited the lowest. To delve into potential physiological activities, molecular docking studies were conducted, predicting the binding affinity of the compounds to proteins 2vf5 (Glucosamine-6-phosphate synthase in complex with glucosamine-6-phosphate) from Escherichia coli, 3cku (rate oxidase from Aspergillus flavus complexed with its inhibitor 8-azaxanthin and chloride) from Aspergillus flavus, and 5IJT (Crystal structure of Human Peroxiredoxin 2 Oxidized). The ensuing analysis of protein-ligand interactions and binding energies underscored the promising physiological activities of the investigated compounds, warranting further exploration for their potential in novel drug development. [Display omitted] • Novel Fe(III) and Cu(II) ions in molar ratios of 1:1 and 1:2 with PHNS ligand complexes have been synthesized. • Their in vitro antibacterial, antifungal, and antioxidant efficacy of the PHNS ligand and its complexes has been investigated. • The CuPHNS complex demonstrated the highest biological activity, while the PHNS ligand exhibited the lowest. • DFT and molecular docking results were correlated with in vitro activities [ABSTRACT FROM AUTHOR]

• Three distinct FeHNANSA, NiHNANSA, and CuHNANSA have been prepared & characterized via a wide variety of analytical methods. • In vitro experiments were conducted to evaluate the antibacterial, antifungal, anti-inflammatory, and antioxidant properties of the prepared compounds. • The metal complexes have heightened biological efficacy as compared to the free HNANSA ligand. • The findings obtained from docking experiments indicate that these compounds may possess a physiological function. Three novel metal complexes of 2‑hydroxy-1-naphthaldehyde azine (HNANSA) with iron(III), nickel(II), and copper(II) have been synthesized and characterized. Various analytical methods, such as elemental analysis, infrared spectroscopy, mass spectrometry, ultraviolet–visible spectroscopy, conductivity, magnetic testing, and thermal analysis, have been used to determine the structural and physical properties of the HNANSA and its metal complexes. The results indicated that; the HNANSA acts as a monobasic bi-dentate NO donor ligand and that the metal complexes contain water molecules in different patterns. Also, density functional theory (DFT) calculations have been performed to confirm the molecular structures and to study the quantum chemical parameters of the HNANSA and its metal complexes. Furthermore, the antibacterial, antifungal, anti-inflammatory, and antioxidant activities of the HNANSA and its metal complexes have been in vitro evaluated. The findings revealed that; the metal complexes have higher bioactivty than the free HNANSA ligand. Furthermore, molecular docking analyses have been performed against 2VF5 (Escherichia coli), 3CKU (Aspergillus flavus), 5IKT (Human Cyclooxygenase-2), and 5IJT (human peroxiredoxin 2), to estimate the binding affinities and interactions of the HNANSA and its metal complexes with target proteins. The results suggest that the HNANSA and its metal complexes may have potential applications in the development of new therapeutic agents. [Display omitted] [ABSTRACT FROM AUTHOR]

[Display omitted] • New Fe(III) (C1), Ni(II) (C2), and Cu(II) (C3) with the ligands moxifloxacin (MOX) and tri-substituted imidazole (TSI) complexes were synthesized and characterized. • The complexes were investigated in vitro for antibacterial efficacy against two gram-positive and two gram-negative bacteria. • The C1, C2, and C3 complexes have been proven to be more biologically effective than a ligand without the antibiotic MOX. • Compared to ascorbic acid, all newly synthesized compounds exhibit similar IC 50 values for free radical scavenging. Herein, three new mixed-ligand complexes were synthesized through the reaction of Fe(III), Ni(II) and Cu(II) with moxifloxacin (MOX) in the presence of tri-substituted imidazole (TSI) to investigate their antibacterial, antifungal, and antioxidant potential. Elemental analysis, molar conductivity, electronic spectra, infrared spectroscopy, mass spectrometry, magnetic studies, thermal gravimetric investigations have been utilized for insuring the chelation process and structural elucidation. Results revealed that MOX and TSI interact with the metal ions via the (carbonyl oxygen and the carboxylic oxygen) and (hydroxyl oxygen and imidazole-ring nitrogen) atoms for MOX, and TSI, respectively. Octahedral geometries have been proposed for the Fe(III), Ni(II) complexes, while a distorted tetrahedral geometry was proposed for the Cu(II) complex. The proposed structures had been optimized via Density functional theory (DFT) calculations. Moreover, the frontier molecular orbitals (FMOs), in terms of HOMO and LUMO, and the molecular electrostatic potential (MEP) were obtained. Furthermore, the energy gap, chemical hardness, softness, chemical potential, electrophilicity index were evaluated. The antimicrobial potential was in vitro investigated against some common pathogenic bacterial and fungal strains; moreover, the antioxidant activity was evaluated using DPPH method. Results revealed that the three synthesized complexes had high antimicrobial activity against all tested phytopathogens and a significant antioxidant potential, compared to the free ligands. Furthermore, the in vitro potential was validated utilizing molecular docking investigation against four target receptors: 5JQ9, 6CLV, 3CKU, and 5IJT. The molecular docking results showed that Fe(III), Ni(II), and Cu(II) complexes had the highest activity towards the 5JQ9, (6CLV and the 3cku), and 5IJT receptors, respectively. [ABSTRACT FROM AUTHOR]

[Display omitted] • Synthesis of new N-(1H-Benzoimidazol-2-yl)-guanidine complexes and their structural elucidation. • Geometry optimization for structural verification utilizing DFT calculation. • DNA interaction and pharmaceutical applications of the prepared compounds. • Molecular docking studies for confirmation of pharmaceutical applications. New medicinally active chelates were prepared from Cu(II), VO(II), Ag(I) and Pd(II) ions with N-(1H-Benzoimidazol-2-yl)-guanidine, BIG ligand. The ligand performed as bi-dentate or Tri-dentate with various transition metals via (HN– &HN = and N =) groups. FT-IR &NMR spectra, CHN-analysis, magnetic moment, electronic spectra, TGA, molar conductance and were applied to characterize the studied compounds. Too stability coefficient for BIG chelates had been systematic in solution, besides pH-profile strength shows the more stability of studied chelates. Theoretical study was applied to abstract important features for BIG and its tested complexes. As well as, 3D-plans of MEP, HOMO-LUMO energies, natural nuclear charges, geometrical parameters were calculated over expressed chk-file through (LANL2DZ & 6-311G basis sets) of DFT, In-silico tests were performed using (2vf5& 3cku& 5IJT& 3gcw) proteins to estimate their physiological performance such as grade of connections, docking patterns and associated factors with biological systems. Special attention was demonstrated through the BIGPd chelate in its interaction with amino acid components and drug-like property. Also, the inhibitory performance was assessed through a scoring function. The bioactivity of the tested compounds was detected over contact with DNA that examined through several methods. In-vitro evaluation has been again agreed out through tested compounds beside various microorganisms, BIGPd and BIGAg exhibited high antimicrobial performance. Moreover, their cytotoxic performance has been studied vs. (HCT‐116, HepG-2, as wellMCF‐7) carcinoma strains, elevated inhibitory effect was noticeably verified through BIGPd as well BIGAg chelates. Additionally, antioxidant performance was scanned by DPPH estimation and the tested chelates displayed high acuteness with abduction free radicals. Lastly, such studied chelates may be reflected as favorable bioactive agents. [ABSTRACT FROM AUTHOR]

• Syntheses of new Co(II), (C1); Ni(II), (C2); Cu(II), (C3) and Zn(II), (C4) complexes. • Characterization of the new complexes using various physicochemical and analytical techniques. • The free ligand and its metal complexes had been applied as disperse dyes on cotton fabrics. • The free ligand and its metal complexes were in vitro investigated for their antimicrobial activity. • Theoretical studies (DFT and molecular docking) were performed. Four Co(II), (C1); Ni(II), (C2); Cu(II), (C3) and Zn(II), (C4) chelates have been synthesized with 1-(4-((2-amino-5‑methoxy)diazenyl)phenyl)ethanone ligand (L). The produced compounds have been identified by using spectral studies, elemental analysis (C.H.N.O), conductivity and magnetic properties. The produced metal chelates were studied using molar ratio as well as sequences contrast types. Rate of concentration (1 ×10−4 - 3 ×10−4 Mol/L) sequence Beer's law. Compound solutions have been noticed height molar absorptivity. The free of ligand and metal chelates had been applied as disperse dyes on cotton fabrics. Furthermore, the antibacterial activity of the produced compounds against various bacteria had been investigated. For the gained datum, a tetrahedral geometrical structure has been suggested for each primed complex. Molecular docking investigation was carried out to ascertain the inhibitory action of the studied compounds against 1HNJ protein, the target enzyme for the antimicrobial agents. The findings showed that, when compared to other compounds, (C1) has the highest binding affinity. Therefore, these molecules might make good candidates for antimicrobials. The quantum chemical parameters are calculated, and the molecular structure complexes were theoretically optimized. [ABSTRACT FROM AUTHOR]

[Display omitted] • New CoCipB, NiCipB, and CuCipB complexes based on Ciprofloxacin and 2-(1H-benzimidazol-2-yl)phenol were synthesized and characterized. • 3D geometry was optimized using the DFT approach. • In vitro antibacterial and antifungal activity was screened. • In vitro antioxidant activity was screened. • Molecular docking against 5JQ9 (E. coli) and 6CLV (S. aureus), 3CKU (As. flavus), and 5IJT (Crystal structure of Human Peroxiredoxin 2 Oxidized) were explored. In the present work, three new Cobalt(II) (CPFX1), Nickel(II) (CPFX2), and Copper (II) (CPFX3) complexes based on Ciprofloxacin (CPFX), and 2-(1H-benzimidazol-2-yl)phenol (2-Bip) were successfully prepared and characterized. The structures were established with the aid of elemental analysis, molar conductance, Electronic spectra, Infra-Red, and mass spectra, in addition to magnetic studies and thermal gravimetric analyses. The results suggest that the Ciprofloxacin (CPFX) and 2-(1H-benzimidazol-2-yl)phenol (2-Bip) ligands behave in the mono-negatively bi-dentate manner through the (Carboxylic Oxygen & pyridine-ring Oxygen) and (hydroxyl Oxygen & benzimidazole-ring Nitrogen), respectively. Both CPFX1 and CPFX2 complexes were predicted to have tetrahedral structures, while the CPFX3 complex was predicted to have an octahedral structure. Quantum chemistry simulations based on density functional theory (DFT) were used to optimize the suggested structures and investigate the nature of the frontier orbitals through frontier molecular orbital (FMO) analysis. These calculations were used to assign sites on the molecules' surfaces using a molecular electrostatic potential map and understand the structure and reactivity behavior using calculated global reactivity descriptors. The antibacterial activity of the prepared complexes was screened in vitro using two Gram-positive bacteria (Bacillus cereus (+ve) and Staphylococcus aureus (+ve)) and two Gram-negative bacteria (Escherichia coli (-ve)) and Pseudomonas aeruginosa (-ve)). For in vitro antifungal testing, Candida albicans and Aspergillus flavus were used. Using the 2,2-Di Phenyl Picryl Hydrazyl (DPPH) assay, we checked the ligands and complexes for their potential antioxidant characteristics. It has been shown that the CPFX1, CPFX2 and CPFX3 complexes are biologically more efficient than the antibiotic CPFX-free ligand. Molecular docking was utilized to determine the most probable main binding paths of the coordination compounds to the microbial enzymes, concluding the biological investigation. Molecular docking simulations were performed on the target proteins Escherichia coli and Staphylococcus aureus , in addition to Aspergillus flavus , and the Crystal Structure of Human Peroxiredoxin 2 Oxidized. The substrate enzyme interacts with the compounds in question by several methods, including H-bonding, and ionic interactions. [ABSTRACT FROM AUTHOR]

Herien, three new Fe(III) (FeAZD), Ni(II) (NiAZD), and Cu(II) (CuAZD) complexes were synthesized and characterized using various physicochemical and spectroscopic approaches. The H 2 AZD ligand acted as a bi-basic bi-dentate NO ligand in a 1:1 molar ratio. The results revealed that the FeAZD and CuAZD complexes had octahedral geometry, while the NiAZD had a tetrahedral geometry. The optimized geometry, HOMO and LUMO analysis of the ligand and its metal complexes was determined via Density functional theory (DFT) using the B3LYP with 6–311 G(d,p), and LanL2DZ level of theory. The FeAZD, NiAZD and CuAZD had lower energy gap, 7.40, 7.93 and 7.06 eV, respectively, than the free ligand (9.58 eV), which proposed that CuAZD was more active one. The free ligand and its metal complexes were in vitro investigated for their antibacterial and antifungal activity. The results illustrated that the metal complexes had higher antibacterial and antifungal activity than the free ligand. More specifically, the CuAZD demonstrated good antibacterial activity against E. coli , P. aeruginosa , S. aureus, B. cereus , and A. flavus , T. rubrum , and C. albicans , with activity indexes of 72.22%, 65.01%, 77.78%, and 72.22%, 63.16%, 59.09%, and 61.90%, respectively. Also, the metal complexes showed lower MIC (6.25–3.125 ppm) compared to the free ligand (about 50 ppm). Finally, molecular docking was utilized to investigate the ability of the free ligand and its metal complexes to inhibit the growth of E. coli (PDB ID: 5iq9). The results showed that the CuAZD had the highest binding affinity to the receptor, with a more negative docking score of − 7.05 Kcal/mol, and lower inhibition constant (Ki) of 6.90 µM. That is indicating that it may be the most effective at inhibiting the growth of E. coli (PDB ID: 5iq9). [Display omitted] • Three FeAZD, NiAZD, and CuAZD complexes were synthesized and characterized. • The complexes had a more promising antimicrobial than the free ligand. • High ability of metal complexes to inhibit the growth of E. coli (PDB ID: 5iq9). • Positive results proposed various medicinal purposes for these compounds. [ABSTRACT FROM AUTHOR]

• Square planar complexes of Ni2+, Pd2+ and Pt2+ with thiosemicarbazone (SNO) ligand. • DMSO coordinate via S to Pd(II) and Pt(II) complexes and X-ray crystal structure. • 3D geometry optimization was investigated using DFT approach. • Molecular docking against tyrosine kinase domain of the EGFR (1M17) was performed. • Cytotoxicity against Hela cancer and normal endothelial human cell lines (Eahy926). The ligand H 2 L with SNO sites and DMSO coordinated to Pd(II) and Pt(II) form square planar [PdL.dmso] and [PtL.dmso] complexes, whereas the Na[NiL.OAc] form with same ligand and CH 3 COO−. FTIR, UV-Vis, and 1H and 13C NMR spectroscopy and micro and physical analysis were used to characterize the compounds. The structures of [PdL.dmso] and [PtL.dmso] complexes were completely elucidated with single crystal X-ray diffraction analysis. The 6–311 G (d, p) and LANL2DZ basis sets of density functional theory (DFT) with the B3LYP approach were utilized to determine the optimal molecular geometries of compounds as well as the HOMO-LUMO energies and other metrics. The [PdL.dmso] showed the highest activity among all the compounds, with an IC 50 of 15.6 µM and a selectivity index (SI) of 2.8 against Hela. The complexes Na[NiL.OAc] and [PtL.dmso] exhibited significant activity against Hela with IC 50 of 105.7 µM and IC 50 of 166 µM respectively, whereas the ligand showed very poor activity. The complexes [PdL.dmso], [PtL.dmso] and ligand, H 2 L exhibited moderate activity against normal Eahy926 with IC 50 values of 43.3 µM, 45 µM, and 185 µM, respectively whereas, the Na[NiL.OAc] showed the highest cytotoxicity with an IC 50 of 5.8 µM. The complexes showed higher activity than free ligand due to the lipophilicity of the chelate. The group 10 metal complexes could be the promising cancer therapeutic agents. The lowest binding energy of -8.16 kcal/mol among all the tested compounds was found for [PdL.dmso] using molecular docking of active site crystal structure of the tyrosine kinase domain of the EGFR (PDB: 1M17). [Display omitted] [ABSTRACT FROM AUTHOR]

[Display omitted] A new Schiff-base ligand, 4-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)hydrazono]methylphenyl 4-methylbenzenesulfonate (L), and its Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes were synthesized and characterized. Elemental analysis, NMR spectroscopy, mass spectra, FT-IR analysis, molar conductivity, magnetic susceptibility tests and electronic spectra (UV-vis.) were all used to describe the ligand and its metal complexes. The complexes of Ni(II) and Zn(II) were found to have a tetrahedral structure, whereas those of Fe(III), Co(II) and Cu(II) exhibited an octahedral structure. The geometry of the ligand and its metal complexes was investigated by density functional theory (DFT) calculations at the B3LYP/6-311G(d, p) and LanL2dz levels of theory, respectively. To round out the picture, we evaluated not only the overall energy but also the HOMO and LUMO molecular orbitals and the molecular electrostatic potential (MEP). The synthetic analogues were tested for their in vitro antibacterial and antifungal efficacy against various pathogens using the disc diffusion method. The research shows that the metal complexes are more effective against these diseases than the free ligand. In addition, the DPPH method was used to measure the antioxidant activity in vitro. The antioxidant activity of each complex was higher than that of its free corresponding ligand. Molecular docking was carried out to determine the interactions between the complexes and the probable binding sites of Human Peroxiredoxin 2 Oxidized (PDB ID: 5IJT) and Escherichia coli (PDB ID: 3t88) receptors. [ABSTRACT FROM AUTHOR]

• Novel VO(II), Mn(II), Fe(III), Zn(II), and Ag(I)-benzenesulfonamide complexes have been synthesized. • The metal complexes have enhanced biological activity against their target microorganisms compared to the unbound ligand. • In vitro research was also conducted on the anti-inflammatory effects of the aforementioned substances. • The prepared compounds have physiological effects and might have broad use in the pharmaceutical industry. In this work, we synthesized and studied novel VO(II), Mn(II), Fe(III), Zn(II), and Ag(I) − 4-((2-hydroxy-1-naphthyl)azo) benzenesulfonamide complexes. Characterization techniques such as thermogravimetry (T.G.A), magnetic susceptibility testing, electrical conductivity studies, infrared spectroscopy, and mass spectroscopy all played crucial roles. Metal ions are coordinated by the azo Nitrogen (N N) and the hydroxyl Oxygen (–OH), as seen by the infrared spectra (IR). Our investigation of water's distribution and thermal behavior, in addition to its overall number, was made possible by techniques from thermogravimetry (T.G.A). The theoretical optimization of ligand (HL) and its metal complexes' molecular structures was accomplished by the use of density functional theory (DFT). Other quantum chemical properties might potentially be derived by using the Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) energy levels. In vitro testing was performed on both the ligand and its complexes to see whether or not they were capable of inhibiting the growth of harmful bacteria and fungi. The metal complexes have enhanced biological activity against the target microorganisms compared to the unbound ligand. In vitro research was also conducted on the anti-inflammatory effects of the aforementioned substances. Surprisingly, the AgL complex was the least active of the compounds tested, while the FeL complex was the most active. Based on molecular docking studies, we hypothesized that the synthesized compounds would bind to the cyclooxygenase-2 (COX-2) enzyme (Protein Data Base (PDB) ID: 5IKT) and the E. coli DNA gyrase B receptor (PDB ID: 1KNZ). Binding energies were calculated after studying protein-substrate interactions in depth. The molecular docking indications are that these compounds have physiological effects and might have broad use in the pharmaceutical industry. [ABSTRACT FROM AUTHOR]

[Display omitted] • Synthesis of new-(((9H-purin-6-yl)imino)methyl)-4-bromophenol complexes and their structural elucidation. • Geometry optimization for structural verification utilizing DFT calculation. • Biomedical applications against pathogens, free radicals and carcinoma cell lines. • Molecular docking studies for confirmation of pharmaceutical applications. Coordination compounds of Ag(I), Cu(II), Ni(II), Fe(III) and VO (II) ions were synthesized from the ligand 2-(((9H-purin-6-yl)imino)methyl)-4-bromophenol (ABS). Microanalysis, magnetic susceptibility, infrared spectroscopy, Ʌ m calculation, and thermal analysis were utilized to inspect the structure of the investigated complexes. As per the data collected, the constitution of the 1:1 cation–adenine imine ligand was found for ABSVO, ABSNi, ABSCu, ABSAg and 1:2 for ABSFe complex. The structural formula for the examined compounds was refined using DFT simulations. The DFT/B3LYP approach was used to calculate the energy gaps and other critical theoretical factors. Moreover, the experimental behavior of the described molecules towards Escherichia coli's glucosamine-6-phosphate synthase (PDB ID: 2vf5), Aspergillus flavus' urate oxidase (PDB ID: 3cku), and the breast cancer oxidoreductase receptor site was rationalized using molecular docking (PDB ID: 3HB5). The hydrogen bonding energies of docked specific receptors were estimated and examined. Furthermore, the inspected metal chelates were subjected to in vitro antibacterial, antifungal, antioxidant and cytotoxicity studies. ABSCu complex showed significant cell growth inhibition activity (IC50 = 5.04 ± 0.07 µg/mL), even higher than the standard anticancer drugs; cisplatin (IC50 = 5.71 ± 0.55 µg/mL) versus breast carcinoma cells. [ABSTRACT FROM AUTHOR]